INTRODUCTION {#SEC1}
============

The transcription by RNA polymerase II (Pol II) consists of several tightly coordinated steps. While the control of transcription initiation has been a long-held paradigm, recent evidence indicates that transcription elongation is another rate-limiting step for governing the rapid expression of inducible genes in metazoans ([@B1]--[@B3]). Genome-wide surveys in different systems reveal that for more than 30% of the transcriptionally active genes, the initiation has completed even at unstimulated state, while the Pol II is yet stalled at the promoter-proximal regions, 20--60 nucleotides downstream of transcription start site ([@B4]--[@B10]). Upon stimulation, the paused Pol II is rapidly released and progressed into productive elongation, leading to the synthesis of full-length mRNA. Moreover, most recent functional studies have revealed that genes regulated by this promoter-proximal pausing step are important in response to the developmental and environmental signals ([@B8],[@B11]--[@B13]).

Although the precise mechanism for promoter--proximal Pol II pausing is still under debate, it is widely accepted that the association of two negative factors, DSIF (DRB sensitivity-inducing factor) and NELF (negative elongation factor), with the initiated Pol II at the promoter--proximal region is essential for Pol II pausing ([@B1]--[@B3],[@B14],[@B15]). While DSIF is a heterodimer of Spt4 and Spt5, NELF is a multisubunit complex consisting of NELF-A, -B, -C/D and -E ([@B15]). Biochemical studies reveal that the interaction of Spt5 and NELF-A with Pol II and the association of NELF-E with nascent mRNA may cooperatively induce Pol II pausing ([@B15]--[@B18]). This Pol II pausing not only acts as a quality checkpoint for 5′-capping of nascent mRNA, but also keeps the promoters in an open state ([@B1],[@B3],[@B19]). The release of paused Pol II depends on the promoter recruitment of positive transcription elongation factor P-TEFb, consisting of Cdk9 and Cyclin T. P-TEFb mediates phosphorylation of the C-terminal domain (CTD) of Pol II at Ser2, the Spt5 of DSIF and the NELF-E of NELF complex. These P-TEFb-mediated phosphorylations are prerequisite for the release of promoter--proximally paused Pol II ([@B1]--[@B3],[@B15],[@B20]--[@B23]).

The activity of P-TEFb is tightly regulated in cells, with majority of P-TEFb sequestrated in an inactive 7SK snRNP complex that contains 7SK snRNA, nuclear proteins HEXIM1/2, MePCE and LARP7 ([@B3],[@B24]). In response to stress, P-TEFb is liberated from 7SK snRNP and is recruited to the promoters via P-TEFb recruitment factors ([@B1],[@B3],[@B25]--[@B27]). Ample evidence indicates that the bromodomain-containing protein Brd4 and the super elongation complex (SEC) are capable of recruiting P-TEFb to promoters ([@B1],[@B3]). Brd4 belongs to BET family that contains two bromodomains and an extraterminal domain ([@B28]). Distinct from the other BET proteins, Brd4 contains a unique P-TEFb interaction domain ([@B29]). Upon stimulation, Brd4 binds to and recruits active form of P-TEFb to promoters to modulate Pol II processivity ([@B30]--[@B32]). SEC is a multisubunit complex consisting one of four AFF scaffold proteins (AFF1--AFF4), one of three ELL proteins (ELL1--ELL3), and an ENL (or its analogue AF9). Depending on cell type, the compositions of SEC can be varied to generate diverse subtypes of SEC ([@B3],[@B33]). Same as Brd4, SEC is able to bind to and recruit P-TEFb to promoters via the interaction with Med26 subunit of Mediator ([@B34]), or Paf1 of polymerase-associated factor complex (Paf1c) ([@B35]). Besides Brd4 and SEC, several sequence-specific DNA-binding transcription factors have been reported to be able to recruit P-TEFb ([@B36]), but some of them were recently found to interact with Brd4/P-TEFb complex, rather than P-TEFb itself ([@B37],[@B38]).

Although emerging evidence indicates that P-TEFb, Brd4 and SEC are essential for the transcription elongation, the detailed mechanism by which these three factors regulate transcription elongation remains unclear. Here, we show that Brd4 and SEC cooperatively regulate the transcriptional pause release by recruiting multiple P-TEFbs via a Mediator- and Paf1c-coordinated recruitment network. Moreover, we demonstrate that the phosphorylation of Ser2 of Pol II CTD is not essential for pausing-to-elongation transition.

MATERIALS AND METHODS {#SEC2}
=====================

Materials {#SEC2-1}
---------

The detailed information of chemicals, antibodies and plasmids are described in Supplementary Information.

Preparation of LSF, HSF and LSEN with stepwise fractionation protocol {#SEC2-2}
---------------------------------------------------------------------

The low-salt fraction (LSF) that contains chromatin-free factors, low-salt extracted nuclei (LSEN) and high-salt fraction (HSF) that contain transcriptionally engaged factors were prepared with stepwise fractionation protocol (see Supplementary Information) ([@B30],[@B31]).

Immunoprecipitation (IP) and Western blot (WB) analysis {#SEC2-3}
-------------------------------------------------------

Flag- or HA-tagged proteins and their associated factors were isolated by anti-Flag or anti-HA IPs from LSF, HSF or nuclear extract (NE) of transfected or infected HeLa cells as previously described ([@B31],[@B39]). The levels of desired proteins in IP products, fractionated samples, NE or cell lysates were analyzed by WB with corresponding antibodies.

Mass spectrometry analysis {#SEC2-4}
--------------------------

To identify the P-TEFb-associated transcriptional factors, the P-TEFb was isolated from HSF of F1C2 (Cdk9-f) cells by anti-Flag affinity purification and analyzed with liquid chromatography electrospray ionization tandem mass spectrometry (LC-MS/MS) system ([@B40],[@B41]). The normalized spectral abundance factors (NSAFs) were applied to calculate each detected protein to estimate relative protein levels ([@B41]). To identify the phospho-residues of NELF-A, HeLa cells expressing Flag-tagged NELF-A (NELF-A-f) were treated with solvent or 10 mM of HMBA for 2 h and subjected to high-salt buffer (0.5 M NaCl) extraction. The anti-Flag affinity-purified NELF-A-f from high-salt extracts was subjected to MS analysis for phosphorylated residues on NELF-A. Three phospho-residues, S374, T288 and T168, were most abundant in spectrum count of 73, 15 and 12 after HMBA treatment. The mass spectrometry data from this publication have been submitted to the PRIDE Archive database at <http://www.ebi.ac.uk/pride/archive/> (see Supplementary Information for details).

*In vitro* kinase assay {#SEC2-5}
-----------------------

For P-TEFb-mediated phosphorylation of T775 of Spt5 or NELF-A, P-TEFb was purified by anti-Flag antibody from HSF of F1C2 (Cdk9-f) cells. Unphosphorylated Spt5 or NELF-A was purified with anti-Flag affinity purification from the NE of HeLa cells expressing Spt5-f or NELF-A-f treated with 300 nM of Flavopiridol for 2 h. The *in vitro* kinase assay was performed as previously described ([@B27]) and the phosphorylation levels were detected by Western blot with a specific anti-phospho-Spt5 antibody. The phosphorylation of NELF-A-f by P-TEFb was detected by WB with antibodies against phospho-Ser (ph-Ser), phospho-Thr (ph-Thr) or phospho-NELF-A.

Luciferase assay {#SEC2-6}
----------------

HeLa cells with an integrated HIV-LTR-luciferase reporter gene (HIV-LTR-Luc) were infected with lentiviruses expressing desired shRNA for 48--96 h, followed by incubation with 5 mM of HMBA for 4--6 h as indicated. Cell lysates were prepared and the luciferase activity was measured as previously described ([@B25]). Data from three replicates were averaged and presented as fold induction compared to untreated cells. All values were expressed as Mean±SD of three replicates. *P*-values were assessed using two-tailed Student\'s *t*-test.

qRT-PCR analysis of transcription elongation products {#SEC2-7}
-----------------------------------------------------

The quantitative real-time polymerase chain reaction (qRT-PCR) was performed as previously described ([@B42]). The qPCR primers corresponding to gene body (+600 bp downstream of transcription start site) were used for analyzing the level of transcription elongation products. The primer sequences are shown in the Supplementary Information. All values were expressed as Mean ± SD of three replicates. *P*-values were assessed using two-tailed Student\'s *t*-test.

Chromatin immunoprecipitation (ChIP)-qPCR {#SEC2-8}
-----------------------------------------

ChIP was performed in HeLa or HCT116 cells and immunoprecipitated DNA was analyzed by qRT-PCR as previously described ([@B39],[@B42]). All values were expressed as Mean ± SD of three replicates. *P*-values were assessed using two-tailed Student\'s *t*-test. The primer sequences used for ChIP-qPCR analysis in this study are shown in the Supplementary Information.

ChIP-silver staining assay {#SEC2-9}
--------------------------

To test the bulk occupancy of RNA Pol II on chromatin, the ChIP was carried out following the protocol of SimpleChIP Enzymatic Chromatin IP Kit (Cell Signaling Technology). In brief, the formaldehyde cross-linked cells were extracted with low-salt buffers to remove the chromatin-free RNA and proteins. The nuclei were then incubated with Micrococcal Nuclease (MNase) (10 μg DNA per 1 unit MNase) to digest genomic DNA to the optimal length (1--2 nucleosomes), followed by sonication to break down the nuclear membrane in the presence of 0.1% SDS. Before ChIP, an aliquot of lysate was removed for WB of the levels of nucleosomal histone H3. ChIP was performed with anti-Rpb1 (Pol II) antibody (40 μg DNA per 1 μg antibody). An aliquot of chromatin immunoprecipitated (ChIPed) DNA was resolved by polyacrylamide gel electrophoresis (PAGE) and visualized by silver staining with the protocol of PlusOne DNA Silver Staining Kit (Cat\#: 17-6000-30, Amersham Biosciences).

ChIP-Seq analysis {#SEC2-10}
-----------------

For ChIP-Seq analysis, the above ChIPed DNAs were subjected to high-throughput sequencing with Illumina HiSeq2500 in RiboBio Co. Ltd. (Guangzhou, China). After quality assessment, the raw ChIP-seq reads were trimmed for adaptor sequences and retained 46 bp from the 3′-end. Reads were then mapped to human genome (GRCh37/hg19) using Bowtie 1.1.1 ([@B43]) with 3-mismatches. Enriched Pol II binding peaks were identified and then annotated by HOMER v4.7 with default settings ([@B44],[@B45]) (<http://biowhat.ucsd>. edu/homer). To calculate Pol II pause ratio (TR), the number of ChIP-seq reads over input background at promoter region (-50 to +300 bp from TSS) and gene body (+300 bp to the end of genes) of each gene was counted by the analyzeRNA.pl command of HOMER with '-tss' option, and then normalized by the concentration of input DNA for ChIP. Only gene length \> 500 bp were analyzed. In order to assess the statistical significance of Pol II pausing, the Benjamini--Hochberg method corrected Fisher\'s exact tests were performed to control the false discovery (*P*-value \< 0.005). The criterion of Pol II pausing was defined as TR (the relative ratio of promoter read density/gene body read density) \>4.0 ([@B6]). The ChIP-seq data from this publication have been submitted to the GEO database at <http://www.ncbi.nlm.nih.gov/geo/> (see Supplementary Information for details).

RESULTS {#SEC3}
=======

Brd4 and SEC are responsible for global recruitment of P-TEFb {#SEC3-1}
-------------------------------------------------------------

Both Brd4 and SEC have been shown to recruit P-TEFb ([@B1]). To compare the difference of these two factors in P-TEFb recruitment, we analyzed Pol II-associated P-TEFb in Brd4 and/or SEC knockdown cells. We used combinatorial knockdown of AFF1 and AFF4 to deplete SEC functions in HeLa and HCT116 cells since only AFF1 and AFF4 of SEC expressed in these cells (Supplementary Figure S1A). Depletion of Brd4 or SEC alone only partially reduced the Pol II-associated P-TEFb, whereas depletion of Brd4 and SEC together abolished almost all the P-TEFb recruitment even in the presence of hexamethylene bisacetamide (HMBA) (Figure [1A](#F1){ref-type="fig"}), a chemical capable of activating P-TEFb ([@B25]). These data indicate that Brd4 and SEC are involved in the global P-TEFb recruitment.

![Brd4 and SEC cooperatively regulate promoter--proximal pausing release. (**A**) The anti-Flag IPs derived from NEs of HeLa cells with indicated f-Rpb5 cDNA and shRNA(s) co-transfection and HMBA treatment were analyzed by WB for the levels of Pol II-associated P-TEFb. The f-Rpt5-bound Rpb1 was also tested to indicate the levels of intact Pol II. shAFF1+4: shAFF1+shAFF4. (**B**) ChIP-Silver staining assay for the effect of Brd4 or AFF1+4 knockdown on the accumulation of Pol II on genomic DNA. The Pol II-bound genomic DNAs from HCT116 cells with indicated shRNA(s) infection and HMBA treatment were chromatin-immunoprecipitated (ChIPed), followed by PAGE resolving and silver staining assay for the accumulation of Pol II on chromatin (top). The histone H3 in cell lysates was examined by WB as a loading control (bottom). (**C**) WB analysis for the effect of Brd4 or AFF1+4 knockdown on HMBA-induced pause release of Pol II. The low-salt extracted nuclei (LSEN), top, low-salt fraction (LSF), middle and cell lysates (bottom) were prepared from HeLa cells with indicated shRNA(s) infection and HMBA treatment. (**D**) The ChIPed DNAs in (B) were subjected to high-throughput sequencing analysis. Venn diagrams display the proportion of promoter--proximal pausing genes before and after HMBA treatment (top) and the proportion of Brd4 or AFF1+4 knockdown-induced pausing genes among the 8203 HMBA-inducible genes under HMBA treatment. Pausing gene: TR \> 4.0, *P*-value \< 0.005. (**E**) The Pol II-bound genomic DNAs were ChIPed from HeLa cells with indicated shRNA(s) infection and HMBA treatment were analyzed by qPCR for the enrichment of Pol II on promoter region of representative genes. The level in shGFP infected cells was set to 1.0. All values were expressed as Mean ± SD of three replicates. *\*P* \< 0.05, *\*\*P* \< 0.01; *P*-values were assessed using two-tailed Student\'s *t*-test. (**F**) Total RNAs isolated from HeLa cells with indicated shRNA(s) infection and HMBA treatment were analyzed by qRT-PCR for mRNA levels of representative genes with primers matching elongation region. The level in untreated cells was set to 1.0. All values were expressed as Mean ± SD of three replicates after normalized to actin. *\*\*P* \< 0.01, *\*\*\*P* \< 0.001; *P*-values were assessed using two-tailed Student\'s *t*-test.](gkw571fig1){#F1}

Both of Brd4 and SEC are required for the release of promoter--proximally paused Pol II {#SEC3-2}
---------------------------------------------------------------------------------------

Since depletion of Brd4 or SEC only partially blocked P-TEFb recruitment (Figure [1A](#F1){ref-type="fig"}), we suspected that such depletion could also partially block the signal-induced release of paused Pol II. To test this hypothesis, we performed chromatin immunoprecipitation (ChIP) and DNA gel resolving and silver staining assay (ChIP-silver staining assay) to examine the release of Pol II (Figure [1B](#F1){ref-type="fig"} and Supplementary Figure S1B). In untreated cells, bulk of Pol II accumulated on genomic DNA and this accumulation was remarkably reduced by HMBA treatment (Figure [1B](#F1){ref-type="fig"}, lane 1 and 2). Unexpectedly, this HMBA-induced release was almost completely blocked by the depletion of either Brd4 or SEC (lane 3 to 6), indicating that Brd4 and SEC are required for the release of the paused Pol II. To further confirm this, we fractionated cells into LSF, which contains chromatin-free proteins, and LSEN, which contains the transcriptionally engaged factors, with a stepwise fractionation protocol (See Supplementary Figure S1C) ([@B30],[@B31]). Immunoblotting analysis of LSEN showed that Pol II, DSIF (Spt5) and NELF (-E) were enriched in the LSEN of untreated cells (Figure [1C](#F1){ref-type="fig"}), and this enrichment was markedly decreased in LSEN after HMBA treatment (lane 2). Interestingly, the decrease was associated with an increase in LSF (lane 2). Of note, the phosphorylated Ser2 (Ser2p) of Pol II CTD was increased during HMBA treatment (Figure [1C](#F1){ref-type="fig"}, lane 2, bottom), indicating that the decrease of Pol II in LSEN is likely due to the efficient transcription induced by HMBA. Consistent with the results of ChIP-silver staining assay, depletion of Brd4 or SEC almost completely blocked HMBA-induced pause release (Figure [1C](#F1){ref-type="fig"}, lane 3--6). These data suggest that both Brd4 and SEC are required for the efficient release of the paused Pol II.

Brd4 and SEC cooperatively regulate the release of promoter--proximally paused Pol II {#SEC3-3}
-------------------------------------------------------------------------------------

To test above notion, we performed Pol II ChIP-Seq to analyze the effect of depletion of Brd4 or SEC on HMBA-induced pause release (Figure [1D](#F1){ref-type="fig"} and Supplementary Table S1). Of 8699 genes with promoter--proximally paused Pol II (pausing genes, TR \> 4, *P*-value \< 0.005), HMBA treatment induced the release of paused Pol II in 8203 genes (94.3%), indicating that HMBA is able to induce global pause release (see Supplementary Figure S1D). Among 8203 HMBA-induced genes, knockdown of Brd4 (shBrd4) inhibited pause release in 5814 genes (70.9%) and depletion of SEC (shAFF1+4) inhibited 7021 genes (85.6%). Importantly, among shBrd4-inhibited genes (5814), 5217 genes (89.7%) were overlapped with SEC-inhibited genes (7021, 74.3%) (Figure [1D](#F1){ref-type="fig"}). Therefore, these data indicate that Brd4 and SEC cooperatively regulate the release of promoter--proximally paused Pol II in most pausing genes. By ChIP-qPCR and qRT-PCR analysis of the representative pausing genes ([@B46],[@B47]), we found that depletion of Brd4 or SEC inhibited HMBA-induced release of paused Pol II and the transcription elongation (Figure [1E](#F1){ref-type="fig"} and [F](#F1){ref-type="fig"}). These data further confirm the notion that Brd4 and SEC cooperatively regulate the pause release. Of note, the relative lower efficiency of pause release inhibition in Brd4 and SEC knockdown cells might be due to the inefficient shRNA(s) knockdown (see Supplementary Figure S1E).

HMBA induces the association of P-TEFb with transcription factors {#SEC3-4}
-----------------------------------------------------------------

To understand the co-regulatory mechanism by Brd4 and SEC in HMBA-induced pause release, we began to explore how Brd4 and SEC mediated P-TEFb recruitment, an essential step for the pause release. We first carried out affinity purification of the transcriptionally engaged Cdk9-f/P-TEFb complexes from HSF (0.3 M salt extract of LSEN, see Supplementary Figure S1C) of F1C2 (Cdk9-f) cells, a HeLa-based cell line stably expressing Flag-tagged Cdk9 ([@B25]), followed by mass spectrometry and WB analysis (Figure [2A](#F2){ref-type="fig"} and [B](#F2){ref-type="fig"}). In line with the stimulatory effect of HMBA on pause release (Figure [1D](#F1){ref-type="fig"}), HMBA induced the association of P-TEFb with a set of critical transcription factors (Figure [2A](#F2){ref-type="fig"} and [B](#F2){ref-type="fig"}). Since knockdown of MePCE, a key component of inactive 7SK snRNP ([@B24]), also induced the association of P-TEFb with transcription factors (Supplementary Figure S2A), indicating that HMBA-induced association (Figure [2A](#F2){ref-type="fig"} and [B](#F2){ref-type="fig"}) is due to the HMBA-induced activation of P-TEFb from 7SK snRNP ([@B25],[@B31]).

![Brd4 and SEC recruit P-TEFbs to DISF and NELF, respectively. (**A**) Cdk9-f immunoprecipitates with anti-Flag affinity resin from HSF of F1C2 (Cdk9-f) cells without or with HMBA treatment were analyzed with LC-MS/MS for Cdk9-associated proteins. The IPs from HeLa cells were served as negative control. The relative abundance of P-TEFb-bound proteins was calculated with NSAF method and the proteins with significant increase after HMBA treatment were shown. (**B**) The IPs were prepared as in (A) and analyzed by WB to confirm the interaction between P-TEFb and its associated factors as indicated in (A). The IPs from HeLa cells were served as negative control. (**C**) P-TEFb and its associated factors were purified with anti-Flag affinity resin from HSF of F1C2 (Cdk9-f) cells with shGFP (as control), shBrd4 or shAFF1+4 infection and HMBA treatment as indicated and analyzed by WB for the indicated proteins. (**D** and **E**) Anti-Flag immunoprecipitates from HSF of HeLa cells with indicated cDNA transfection and HMBA treatment were analyzed by WB for the indicated proteins.](gkw571fig2){#F2}

The P-TEFb recruited by Brd4 and SEC targets DSIF and NELF, respectively {#SEC3-5}
------------------------------------------------------------------------

Since DSIF and NELF are important factors for the Pol II pausing, we next investigated whether they are involved in Brd4 and SEC co-regulated release of paused Pol II. We knocked down Brd4 or AFF1+4 in F1C2 (Cdk9-f) cells and immunoprecipitated Cdk9-f/P-TEFb complexes from HSF in 0.3 M salt concentration as in Figure [2B](#F2){ref-type="fig"}. Immunoblotting analysis of the immunoprecipitated complexes revealed that depletion of Brd4 specifically abolished the association of P-TEFb with DSIF (Spt5), Med1 and Med23 subunits of Mediator, and Tat-SF1, whereas depletion of SEC specifically impaired the association of P-TEFb to NELF (-A and -E), Med26 of Mediator, and Paf1 subunit of Paf1c complex (Figure [2C](#F2){ref-type="fig"}), indicating that the transcription factors associated with Brd4/P-TEFb complex are different from those associated with SEC/P-TEFb complex. Intriguingly, two critical subunits of middle module of Mediator, Med1 and Med26, bound to Brd4/P-TEFb and SEC/P-TEFb, respectively. To further confirm these interactions, we performed immunoprecipitation with different salt concentration to determine whether these interactions could be affected by salt concentration. Immunoblotting analysis of the immunoprecipitated complexes showed that 0.3 M salt concentration disrupted the association between Med1 and Med26, but not the binding of Brd4/P-TEFb to Med1 or SEC/P-TEFb to Med26, whereas 0.15 M had no effect on these interactions (Supplementary Figure S2B). These data suggest that Med1 and Med26 bind to different P-TEFb complexes, even though they coexist in the same middle module of Mediator. Consistently, knockdown of Med26 did not affect the binding of Brd4/P-TEFb to Med1, and depletion of Med1 had no effect on the interaction of SEC/P-TEFb with Med26 (Supplementary Figure S2C). Together, these data demonstrate that P-TEFb recruited by Brd4 or SEC interacts with Med1 or Med26, respectively.

To further analyze these interactions, we compared the anti-Flag immunoprecipitates derived from HSF of HeLa cells expressing Med1-f, Med23-f, Tat-SF1-f or Spt5-f, with the immunoprecipitates from HSF of Cdk9-f and Brd4-f cells as positive control (Figure [2D](#F2){ref-type="fig"}). Interestingly, while DSIF (Spt5) only bound to P-TEFb (Figure [2D](#F2){ref-type="fig"}, lane 6), Med1, Med23 and Tat-SF1 bound to both Brd4 and P-TEFb (lane 2 to 5), implying that Med1, Med23 and Tat-SF1 might be involved in the recruitment of Brd4/P-TEFb complex, with Spt5/DSIF being the end point of P-TEFb. Immunoblotting analysis of the immunoprecipitates derived from HSF of HeLa cells expressing Med26-f, Paf1-f, NELF-A-f or NELF-E-f showed that all four proteins bound to P-TEFb, but only Med26 and Paf1 bound to scaffold protein AFF1 and AFF4 (Figure [2E](#F2){ref-type="fig"}). These data implicate that Med26 and Paf1 might be engaged in the recruitment of SEC/P-TEFb, with NELF complex being the end point of P-TEFb. Surprisingly, only NELF-A, but not NELF-E, bound to ENL/AF9 (Figure [2E](#F2){ref-type="fig"}, lane 3 and 4), suggesting that NELF-A and NELF-E might interact with different SEC subtypes. Similar to Med1 and Med26 (Supplementary Figure S2B), 0.3 M salt concentration disrupted the interaction between NELF-A and NELF-E, but not the binding of NELF-A to both P-TEFb and ENL or the association of NELF-E to P-TEFb (Supplementary Figure S2D). More specifically, knockdown of NELF-E failed to disrupt the binding of NELF-A to both P-TEFb and ENL, and depletion of NELF-A also failed to change the binding of NELF-E to P-TEFb (Supplementary Figure S2E), indicating that the SEC/P-TEFb subtypes in associating with NELF-A are different from those in association with NELF-E (see below for details).

Collectively, these data demonstrate that Brd4 or SEC recruits different pool of P-TEFb to target DSIF or NELF, respectively, for the co-regulated pause release of Pol II.

Brd4 recruits P-TEFb to DSIF via a recruitment pathway consisting of Med1, Med23 and Tat-SF1 {#SEC3-6}
--------------------------------------------------------------------------------------------

To investigate the role of Med1, Med23 and Tat-SF1 in Brd4/P-TEFb recruitment, we first evaluated the effect of knockdown of these factors on pause release. Similar to Brd4 knockdown (Figure [1C](#F1){ref-type="fig"}, [E](#F1){ref-type="fig"} and [F](#F1){ref-type="fig"}), depletion of any one of these factors blocked HMBA-induced pause release (Figure [3A](#F3){ref-type="fig"} and [B](#F3){ref-type="fig"}) and transcription elongation (Supplementary Figure S3A), suggesting that Med1, Med23 and Tat-SF1 have a non-redundant role in pause release, very likely, through recruiting Brd4/P-TEFb to DSIF.

![The P-TEFb targeting DSIF is recruited by Brd4 via a recruitment pathway consisting of Med1, Med23 and Tat-SF1. (**A**) The Pol II-bound genomic DNAs ChIPed from HeLa cells with indicated shRNA infection and HMBA treatment were analyzed by qPCR for the enrichment of Pol II on the promoter region of representative genes as in Figure [1E](#F1){ref-type="fig"}. The level in shGFP infected cells was set to 1.0. All values were expressed as Mean ± SD of three replicates. *\*P* \< 0.05, *\*\*P* \< 0.01, *\*\*\*P* \< 0.001; *P*-values were assessed using two-tailed Student\'s *t*-test. (**B**) LSEN from HeLa cells with indicated shRNA infection and HMBA treatment were analyzed by WB as in Figure [1C](#F1){ref-type="fig"}. (**C**) Effect of depletion of Brd4, Med1, Med23 or Tat-SF1 on the recruitment of P-TEFb to DSIF (Spt5) and NELF (-E). Anti-Flag immunoprecipitates from NEs of F1C2 (Cdk9-f) cells with indicated shRNA infection and HMBA treatment were analyzed by WB for the indicated Cdk9-f/P-TEFb-associated proteins. (**D**) Effect of JQ1 on P-TEFb recruitment to Spt5/DSIF (left panel) and P-TEFb-mediated phosphorylation of Spt5 (pT775-Spt5, right panel). The anti-Flag immunoprecipitates from NEs of F1C2 (Cdk9-f) (left panel) and the cell lysates of HeLa cells (right panel) with indicated JQ1 and HMBA treatment were analyzed by WB for the indicated proteins. (**E**) Effect of Spt5 phosphorylation on the dissociation of NELF. The anti-Flag immunoprecipitates from NEs of HeLa cells with indicated Spt5-f cDNA and shRNA co-transfection (left) or with WT- or ΔCTR-Spt5-f transfection (right) were analyzed by WB for the levels of NELF-A and NELF-E and the levels of phosphorylated Spt5 (pT775-Spt5).](gkw571fig3){#F3}

To prove this hypothesis, we knocked down these factors one by one in F1C2 (Cdk9-f) cells and examined the interaction of P-TEFb with relevant factors (Figure [3C](#F3){ref-type="fig"}). As shown in Figure [3C](#F3){ref-type="fig"}, depletion of Brd4 blocked the binding of P-TEFb to Med1, Med23, Tat-SF1 and DSIF (Figure [3C](#F3){ref-type="fig"}, lane 2). Interestingly, depletion of Med1 blocked the binding of P-TEFb to Med23, Tat-SF1 and DSIF, but not to Brd4 (lane 3), whereas depletion of Med23 blocked the binding of P-TEFb to Tat-SF1 and DSIF, but not to Brd4 and Med1 (lane 4). Finally, depletion of Tat-SF1 only abolished the binding of P-TEFb to DSIF (lane 5). Similarly, pre-treatment of the cells with Brd4 specific inhibitor JQ1 ([@B28],[@B48]) also blocked the recruitment of P-TEFb to DSIF by impairing the association of Brd4/P-TEFb with Med1, Med23 and Tat-SF1 (Figure [3D](#F3){ref-type="fig"}, left panel). Importantly, the recruitment of P-TEFb to NELF was not affected in those knockdown cells (Figure [3C](#F3){ref-type="fig"}). Together with the data in Figure [2C](#F2){ref-type="fig"} and [D](#F2){ref-type="fig"}, these data indicate that Brd4 recruits P-TEFb to DSIF via a specific recruitment pathway consisting of Med1, Med23 and Tat-SF1.

P-TEFb-mediated phosphorylation of Spt5 is essential for the dissociation of NELF from Spt5/DSIF {#SEC3-7}
------------------------------------------------------------------------------------------------

P-TEFb is capable of phosphorylating C-terminal region (CTR) of Spt5 ([@B22]). Therefore, we generated an antibody that specifically recognized P-TEFb-mediated phosphorylation of T775 of Spt5 CTR (pT775-Spt5) (Supplementary Figure S3B). Consistent with the inhibitory effect on pause release (Figure [3B](#F3){ref-type="fig"}), depletion of Brd4, Med1, Med23 or Tat-SF1 all blocked Spt5 phosphorylation (Supplementary Figure S3C). Moreover, pre-treatment with JQ1 not only blocked Spt5 phosphorylation, but also impaired the dissociation of NELF and the pause release (Figure [3D](#F3){ref-type="fig"}, right panel), suggesting that the phosphorylation of Spt5 might be essential for the dissociation of NELF. Further supporting this, we found that depletion of Brd4 or expression of CTR-deleted Spt5-f (ΔCTR-Spt5-f) blocked the dissociation of NELF from Spt5/DSIF by inhibiting Spt5 phosphorylation (Figure [3E](#F3){ref-type="fig"}).

Taken together, the data in Figure [3](#F3){ref-type="fig"} reveal that Brd4 recruits P-TEFb to DSIF via a recruitment pathway consisting of Med1, Med23 and Tat-SF1. These data also indicate that P-TEFb-mediated Spt5 phosphorylation is required for the dissociation of NELF from DSIF and Pol II (see Supplementary Figure S3D for illustrated model).

SEC recruits P-TEFb to NELF-A and NELF-E via Paf1c and Med26, respectively {#SEC3-8}
--------------------------------------------------------------------------

Since depletion of SEC blocked the binding of P-TEFb to Med26 and Paf1 (Figure [2C](#F2){ref-type="fig"}), we next evaluated whether these two factors might contribute to a SEC/P-TEFb recruitment pathway. Depletion of Med26 or Paf1 blocked HMBA-induced pause release by impairing the dissociation of NELF (-A and -E) from promoter regions (Figure [4A](#F4){ref-type="fig"} and [B](#F4){ref-type="fig"}). These data indicate that both Med26 and Paf1 are essential for pause release, most likely, by mediating the recruitment of SEC/P-TEFb to NELF.

![SEC recruits P-TEFbs to NELF-A and NELF-E via Paf1c and Med26, respectively. (**A**) Effect of depletion of Med26 and Paf1 on HMBA-stimulated dissociation of NELF-A and NELF-E. The DNAs ChIPed from HeLa cells with indicated shRNA(s) infection and HMBA treatment were analyzed by qPCR for the enrichment of NELF-A and NELF-E on the promoter region of representative genes as in Figure [1E](#F1){ref-type="fig"}. The level in shGFP infected cells was set to 1.0. All values were expressed as Mean ± SD of three replicates. *\*P* \< 0.05, *\*\*P* \< 0.01; *P*-values were assessed using two-tailed Student\'s *t*-test. (**B**) LSEN prepared from HeLa cells with indicated shRNA(s) infection and HMBA treatment were analyzed by WB as in Figure [1C](#F1){ref-type="fig"}. (**C**) Effect of depletion of Med26 and Paf1 on P-TEFb recruitment to NELF. The anti-Flag immunoprecipitates from NEs of F1C2 (Cdk9-f) cells with indicated shRNA infection and HMBA treatment were analyzed by WB for the levels of the indicated Cdk9-f/P-TEFb-associated proteins. (**D**) Effect of depletion of Med26 and Paf1 on P-TEFb-mediated phosphorylation of NELF-A. The anti-Flag immunoprecipitates from HeLa cells with indicated NELF-A-f cDNA and shRNA co-transfection and HMBA treatment were analyzed by WB for the levels of phosphorylated NELF-A (pS374-NELF-A). (**E**) Effect of overexpression of 3A-NELF-A on HMBA-induced pause release. The LSEN prepared from HeLa cells with WT- and 3A-NELF-A-f infection and HMBA treatment as indicated were analyzed by WB as in Figure [1C](#F1){ref-type="fig"}. (**F**) HeLa cells stably integrated a HIV-LTR-luciferase reporter gene (HIV-LTR-Luc) were overexpressed with WT- or 3A-NELF-A, followed by HMBA treatment as indicated. The cell lysates prepared from the cells were subjected to luciferase assay. The level in untreated cells was set to 1.0. All values were expressed as Mean ± SD of three replicates. *\*P* \< 0.01, *\*\*P* \< 0.001; *P*-values were assessed using two-tailed Student\'s *t*-test.](gkw571fig4){#F4}

We next examined the effect of Med26 and Paf1 knockdown on the binding of P-TEFb to NELF in F1C2 (Cdk9-f) cells. Unexpectedly, depletion of Med26 only blocked the association of P-TEFb with NELF-E, but not with NELF-A and Paf1, whereas depletion of Paf1 abolished the binding of P-TEFb to NELF-A, but not to NELF-E and Med26 (Figure [4C](#F4){ref-type="fig"}). Moreover, in the absence of NELF-A or NELF-E, which did not change the binding of P-TEFb to NELF-E or to NELF-A, respectively (Supplementary Figure S4A, lane 1 and 4), depletion of Med26 specifically abolished the recruitment of P-TEFb to NELF-E (lane 2), whereas depletion of Paf1 only impaired the recruitment of P-TEFb to NELF-A (lane 6). These data indicate that Med26 specifically mediates the recruitment of P-TEFb to NELF-E, whereas Paf1c mediates the recruitment of P-TEFb to NELF-A.

P-TEFb-mediated phosphorylation of NELF-A is essential for pause release {#SEC3-9}
------------------------------------------------------------------------

P-TEFb has been shown to phosphorylate NELF-E ([@B21]), but whether NELF-A could be phosphorylated by P-TEFb is not clear. To answer this question, we first determined whether NELF-A could be phosphorylated in cells by mass spectrometry. Analyzing mass spectrometry data of immunoprecipitated NELF-A from HeLa cells stably expressing NELF-A, we identified three phospho-residues, including threonines (T) 168, 288 and serine (S) 374 (Supplementary Figure S4B). We next substituted all three amino acids to alanines to generate a phosphorylation-defective mutant of NELF-A (T168A/T288A/S374A, designated as 3A-NELF-A). *In vitro* kinase assay followed by immunoblotting analysis with antibody against phospho-Ser (ph-Ser) or phospho-Thr (ph-Thr) revealed that P-TEFb directly phosphorylated WT NELF-A but not 3A-NELF-A (Supplementary Figure S4C). Phosphorylated NELF-A could also be detected in cultured cells by an antibody that specifically recognizes phosphorylated S374 of NELF-A (pS374-NELF-A) (Supplementary Figure S4D).

Consistent with the inhibitory effect of knocking down Paf1 on the binding of P-TEFb to NELF-A (Figure [4C](#F4){ref-type="fig"}), depletion of Paf1, but not Med26, inhibited the phosphorylation of NELF-A at S374 (Figure [4D](#F4){ref-type="fig"}). Moreover, overexpression of 3A-NELF-A blocked HMBA-induced pause release (Figure [4E](#F4){ref-type="fig"}) and the transcription of HIV-LTR-driven luciferase reporter gene (HIV-LTR-Luc, Figure [4F](#F4){ref-type="fig"}). These data suggest that Paf1c-delivered P-TEFb could phosphorylate NELF-A, leading to the pause release of Pol II.

The P-TEFb targeting NELF-A or NELF-E is recruited by different SEC subtypes {#SEC3-10}
----------------------------------------------------------------------------

Given that SEC is essential for recruiting P-TEFb to NELF (Figure [4](#F4){ref-type="fig"}) and there are diverse SEC subtypes in cells ([@B33]), we next determined the functional difference of SEC subtypes in P-TEFb recruitment. Since ENL and AF9 bound to NELF-A, but not to NELF-E (Figure [2E](#F2){ref-type="fig"} and Supplementary Figure S2D and E), we first assessed the role of ENL and AF9 in P-TEFb recruitment. Depletion of ENL or AF9 alone had little effect on the binding of P-TEFb to NELF-A and Paf1 (Figure [5A](#F5){ref-type="fig"}). However, depletion of both ENL and AF9 at the same time significantly inhibited the binding of P-TEFb to NELF-A and Paf1 (Figure [5A](#F5){ref-type="fig"}). The binding of P-TEFb to NELF-E and Med26 was not affected by the depletion of ENL and/or AF9 (Figure [5A](#F5){ref-type="fig"}). These data indicate that the SEC subtype containing ENL or AF9 has redundant role in recruiting P-TEFb to NELF-A, but has no function in recruiting P-TEFb to NELF-E.

![The P-TEFbs targeting NELF-A and NELF-E are recruited by distinct SEC subtypes. (**A** and **B**) The anti-Flag immunoprecipitates from NEs of HeLa cells with Cdk9-f cDNA and shRNA(s) co-transfection and HMBA treatment as indicated were analyzed by WB for the levels of indicated Cdk9-f/P-TEFb-associated proteins. (**C** and **D**) The anti-Flag immunoprecipitates derived from NEs of cells with indicated cDNA and shRNA(s) co-transfection and HMBA treatment were analyzed by WB for the levels of indicated proteins in association with Paf1c-f (C) or Med26-f (D). (**E**) LSEN of HeLa cells with indicated shRNA infection and HMBA treatment were analyzed by WB for the levels of indicated proteins. (**F**) ChIP-qPCR analysis for the enrichment of Pol II at the promoter region of representative genes in HeLa cells with indicated shRNA infection and HMBA treatment as in Figure [1E](#F1){ref-type="fig"}. The level in shGFP infected cells was set to 1.0. All values were expressed as Mean ± SD of three replicates. *\*P* \< 0.05, *\*\*P* \< 0.01; *P*-values were assessed using two-tailed Student\'s *t*-test.](gkw571fig5){#F5}

Since both AFF1 and AFF4 bound to Med26 and Paf1 (Figure [2E](#F2){ref-type="fig"}), we next evaluated the effect of depletion of AFF1 and/or AFF4 on P-TEFb recruitment. Interestingly, depletion of AFF1, but not AFF4, impaired the binding of P-TEFb to Paf1 and NELF-A (Figure [5B](#F5){ref-type="fig"}). The interactions of P-TEFb with Med26 and NELF-E were abolished only when both AFF1 and AFF4 were depleted (Figure [5B](#F5){ref-type="fig"} and Supplementary Figure S5A). Consistently, depletion of AFF1, but not AFF4, impaired the P-TEFb-mediated NELF-A phosphorylation (Supplementary Figure S5B). Examining the factors in association with Paf1-f or Med26-f indicated that depletion of AFF1 alone blocked the binding of Paf1 to P-TEFb, ENL and AF9, but not the binding of Med26 to NELF-E (Figure [5C](#F5){ref-type="fig"} and [D](#F5){ref-type="fig"}, lane 2). Depletion of AFF1 and AFF4 together abolished the binding of both Paf1 and Med26 to P-TEFb (lane 4). These data suggest an essential role of AFF1 but not AFF4 in pause release. Consistent with this notion, depletion of AFF1 alone inhibited HMBA-induced pause release (Figure [5E](#F5){ref-type="fig"} and [F](#F5){ref-type="fig"}) and transcription elongation (Supplementary Figure S5C).

Collectively, the data in Figures [4](#F4){ref-type="fig"} and [5](#F5){ref-type="fig"} reveal that both AFF1-SEC and AFF4-SEC subtypes are able to recruit P-TEFb to NELF-E via Med26, whereas both AFF1-ENL-SEC and AFF1-AF9-SEC subtypes are responsible for the recruitment of another P-TEFb to NELF-A via Paf1c. In addition to the phosphorylation of NELF-E ([@B21]), P-TEFb-mediated phosphorylation of NELF-A is also required for the dissociation of NELF from paused Pol II (see Supplementary Figure S5D for illustrated model).

The P-TEFb responsible for phosphorylation of Pol II Ser2 is recruited by AFF4-ENL (AF9)-SEC with Paf1c being a docking site {#SEC3-11}
----------------------------------------------------------------------------------------------------------------------------

The phosphorylation of Ser2 of Pol II CTD by P-TEFb has long been shown to be a prerequisite for pause release ([@B14]). Given that multiple P-TEFbs are recruited to Spt5/DSIF and NELF (-A and -E), we investigated whether depletion of Spt5/DSIF and NELF (A+E) could affect Ser2 phosphorylation. Interestingly, depletion of Spt5 or NELF (A+E) did not affect Ser2 phosphorylation, but led to the transcription elongation even without HMBA stimulation (Supplementary Figure S6A and B). Thus, we determined the effect of depletion of Brd4, AFF1 or AFF4 on Ser2 phosphorylation in the presence or absence of Spt5. In the presence of Spt5, depletion of any one of these three factors inhibited Ser2 phosphorylation (Figure [6A](#F6){ref-type="fig"}). However, in the absence of Spt5 with the enhanced transcription elongation (Supplementary Figure S6B), only AFF4 depletion inhibited Ser2 phosphorylation (Figure [6A](#F6){ref-type="fig"}, lane 10). This effect could also be observed in the absence of NELF (A+E) (Supplementary Figure S6C). ChIP-qPCR assay showed that depletion of AFF4, but not AFF1, decreased the levels of Pol II Ser2 phosphorylation at the termination regions (Figure [6B](#F6){ref-type="fig"}), likely due to the impairment of P-TEFb recruitment (Figure [6C](#F6){ref-type="fig"}). Of note, although both Med26 and Paf1 bound to and recruited SEC/P-TEFb (Figure [5](#F5){ref-type="fig"}), only depletion of Paf1, but not Med26, abolished Ser2 phosphorylation in the absence of Spt5 (Figure [6A](#F6){ref-type="fig"}, lane 13). Moreover, in the absence of Spt5, depletion of AFF4, but not AFF1, blocked the binding of Paf1-f to P-TEFb, ENL and AF9 (Figure [6D](#F6){ref-type="fig"}). Collectively, these data demonstrate that AFF4-ENL-SEC and AFF4-AF9-SEC subtypes are responsible for recruiting P-TEFb for Ser2 phosphorylation using Paf1c as a docking site.

![The P-TEFb responsible for the phosphorylation of Pol II Ser2 is recruited by AFF4-ENL (AF9)-SEC with Paf1c being the docking site. (**A**) WB analysis of the levels of phosphorylated Ser2 (Ser2p) and Ser5 (Ser5p) in HeLa cell lysates with indicated shRNAs co-infection. (**B**) Effect of depleting AFF1 or AFF4 in the absence or presence of Spt5 on the enrichment of Ser2p Pol II at the termination region of tested genes, The DNAs ChIPed with anti-Ser2p or anti-Pol II antibody from HeLa cells with indicated shRNAs co-infection were analyzed by qPCR. The ratio of Ser2p Pol II to bulk Pol II was shown. All values were expressed as Mean ± SD of three replicates. *\*\*P* \< 0.01, *\*\*\*P* \< 0.001; *P*-values were assessed using two-tailed Student\'s *t*-test. (**C**) Effect of depleting AFF1 or AFF4 in the absence of Spt5 on the recruitment of P-TEFb at the termination region of tested genes. The DNAs ChIPed from HeLa cells with indicated shRNAs co-infection were analyzed by qPCR as in (B). All values were expressed as Mean ± SD of three replicates. *\*\*P* \< 0.01, *\*\*\*P* \< 0.001; *P*-values were assessed using two-tailed Student\'s *t*-test. (**D**) The anti-Flag immunoprecipitates from NEs of HeLa cells with Paf1-f cDNA and shRNA co-transfection and HMBA treatment as indicated were analyzed by WB for the levels of indicated Paf1-f-associated proteins.](gkw571fig6){#F6}

The P-TEFb-mediated Ser2 phosphorylation is not essential for pause release {#SEC3-12}
---------------------------------------------------------------------------

Since depletion of Brd4 and AFF1 abolished Ser2 phosphorylation only in the presence of Spt5/DSIF (Figure [6A](#F6){ref-type="fig"}), and Brd4 and AFF1 are required for pause release (Figures [3](#F3){ref-type="fig"}--[5](#F5){ref-type="fig"}), it raised the possibility that Ser2 phosphorylation might occur after pause release. Indeed, overexpression of ΔCTR-Spt5, which blocked pause release (Figure [7A](#F7){ref-type="fig"}, bottom, lane 4), inhibited Ser2 phosphorylation (top). In addition, depletion of Cdk9 markedly abolished Ser2 phosphorylation (Figure [7B](#F7){ref-type="fig"}), but did not impair the transcription elongation and pause release in the absence of Spt5/DSIF (Figure [7C](#F7){ref-type="fig"} and [D](#F7){ref-type="fig"}). Furthermore, depletion of AFF4 markedly abolished Ser2 phosphorylation (Figure [7E](#F7){ref-type="fig"}, top), but only slightly blocked HMBA-induced pause release even in the presence of DSIF (Figure [7E](#F7){ref-type="fig"}, bottom). Consistently, among 8203 HMBA-inducible genes, AFF4 depletion only blocked the release of promoter-proximally paused Pol II in 1467 genes (17.9%) (pausing genes, TR \> 4, *P*-value \< 0.005), as indicated by Pol II ChIP-Seq analysis (Figure [7F](#F7){ref-type="fig"} and Supplementary Table S2). Taken together, these data demonstrate that P-TEFb-mediated Ser2 phosphorylation is dispensable for promoter-proximal pause release.

![The P-TEFb-mediated Ser2 phosphorylation is dispensable for pause release. (**A**) WB analysis of the effect of ΔCTR-Spt5 on HMBA-induced Ser2p and pause release. The cell lysates (top) and LSEN (bottom) from 293T cells with indicated WT- or ΔCTR-Spt5-f transfection and HMBA treatment were analyzed for the levels of indicated proteins. (**B**) WB analysis of Ser2p, Ser5p and indicated proteins in cell lysates of HeLa cells with co-infection of shSpt5 and shCdk9 as indicated. (**C**) qRT-PCR analysis for the mRNA levels of representative genes in cells with indicated shRNA(s) co-infection as in Figure [1F](#F1){ref-type="fig"}. All values were expressed as Mean ± SD of three replicates. *\*\*P* \< 0.01; *P*-values were assessed using two-tailed Student\'s *t*-test. (**D**) Effect of depletion of Cdk9 and Spt5 on the enrichment of Pol II on the promoter region of tested genes. The DNAs ChIPed from HeLa cells co-infected with indicated shRNA(s) were analyzed by qPCR as in Figure [1E](#F1){ref-type="fig"}. All values were expressed as Mean ± SD of three replicates. *\*\*P* \< 0.01; *P*-values were assessed using two-tailed Student\'s *t*-test. (**E**) WB analysis of the effect of knockdown AFF4 on Ser2p and pause release. LSEN and cell lysates from HeLa cells with shRNA(s) infection and HMBA treatment were analyzed for the levels of indicated proteins. (**F**) ChIP-Seq analysis of the effect of AFF4 knockdown on HMBA-induced pause release as in Figure [1D](#F1){ref-type="fig"}. Diagrams display the proportion of pause-released genes in HCT116 cells with or without AFF4 knockdown under HMBA treatment. The criterion of Pol II pausing was defined as TR (the relative ratio of promoter read density/gene body read density) \> 4.0, *P*-value \< 0.005.](gkw571fig7){#F7}

DISCUSSIONS {#SEC4}
===========

P-TEFb, Brd4 and SEC play essential roles in regulating transcription elongation. However, the detailed mechanism by which Brd4 and SEC recruit P-TEFb for pause release remains elusive. In the present study, we demonstrate that Brd4 and SEC cooperatively regulate transcriptional pause release by recruiting multiple P-TEFbs via different recruitment mechanisms (Figure [8](#F8){ref-type="fig"}). To release a promoter-proximally paused Pol II, Brd4 recruits the first P-TEFb to DSIF via a specific recruitment pathway consisting of Med1, Med23 and Tat-SF1, leading to the phosphorylation of Spt5 (Figure [8](#F8){ref-type="fig"}). Meanwhile, AFF1-SEC or AFF4-SEC recruits the second P-TEFb to NELF-E via Med26, and AFF1-ENL (AF9)-SEC recruits the third P-TEFb to NELF-A via Paf1c, leading to the phosphorylation of NELF-E and NELF-A and the dissociation of NELF from paused Pol II (Figure [8](#F8){ref-type="fig"}). Finally, AFF4-ENL (AF9)-SEC recruits the P-TEFb to Paf1c to phosphorylate Pol II CTD at Ser2 (Figure [8](#F8){ref-type="fig"}). Thus, the transcriptional pause release is regulated by the cooperation of multiple P-TEFbs which are recruited by Brd4 and SEC subtypes via a Mediator- and Paf1c-coordinated recruitment network.

![Model of Brd4 and SEC cooperatively regulating pause release of Pol II. A model depicting the co-regulation processes of transcriptional pause release by Brd4 and SEC through recruiting multiple P-TEFbs via Mediator- and Paf1c-coordinated recruitment network. The number in blue square denotes the P-TEFb recruited by distinct mechanism as indicated.](gkw571fig8){#F8}

The mechanisms of multiple P-TEFbs-mediated pause release {#SEC4-1}
---------------------------------------------------------

It has been widely accepted that P-TEFb-mediated phosphorylation of Ser2 of Pol II, the Spt5 of DSIF and the NELF-E of NELF is a prerequisite for the release of promoter--proximally paused Pol II ([@B1]--[@B3],[@B15],[@B23]). In this study, we found that these three different phosphorylations are mediated by three 'appointed' P-TEFbs (Figure [8](#F8){ref-type="fig"}). Moreover, in addition to NELF-E, NELF-A is also phosphorylated by an 'appointed' P-TEFb (Figure [5](#F5){ref-type="fig"}). Therefore, it requires at least four 'appointed' P-TEFbs to convert paused transcription to productive elongation (Figure [8](#F8){ref-type="fig"}).

The dissociation of NELF from paused Pol II is a key step for pause release ([@B15],[@B23]). Since NELF-A associates with Pol II, and NELF-E binds to nascent mRNA ([@B15],[@B16],[@B18]), it is reasonable to assume that both NELF-A and NELF-E have to be phosphorylated in order to dissociate NELF from promoter--proximally paused Pol II. Importantly, besides the phosphorylation of NELF-A and NELF-E, our data demonstrated that the phosphorylation of Spt5 CTR was also essential for the dissociation of NELF from paused Pol II (Figure [3](#F3){ref-type="fig"}). Given that the association of NELF with Pol II depends on its interaction with DSIF ([@B16]), it is conceivable that the phosphorylation of Spt5 might facilitate the disruption of the interaction between DSIF and NELF and the dissociation of NELF from DSIF (Figure [3](#F3){ref-type="fig"}). This feature might provide a plausible answer to how DSIF is transited from a negative factor to a positive factor in transcription elongation after the phosphorylation of Spt5 CTR ([@B22]). Moreover, the necessity of P-TEFb-mediated phosphorylation of both Spt5 and NELF for the dissociation of NELF from paused Pol II could be the underlying mechanism for Brd4- and SEC-mediated co-regulation of pause release.

It is commonly believed that the phosphorylation of Pol II CTD at Ser2 is essential for the release of promoter--proximally paused Pol II ([@B15]). Different from this notion, our data indicate that Ser2 phosphorylation is dispensable for pause release (Figure [7](#F7){ref-type="fig"} and [8](#F8){ref-type="fig"}). First, in the absence of Spt5/DSIF, depletion of Cdk9 abolished Ser2 phosphorylation, but it did not affect the pause release and transcription elongation (Figure [7B](#F7){ref-type="fig"} to D). Second, in the presence of DSIF, depletion of AFF4 severely impaired Ser2 phosphorylation, but only slightly affected the release of promoter--proximally paused Pol II (Figure [7E](#F7){ref-type="fig"} and [F](#F7){ref-type="fig"}). Finally, in the presence of DSIF, depletion of AFF1, which is required for the recruitment of P-TEFb to NELF-A for pause release (Figure [5](#F5){ref-type="fig"}), blocked the binding of Paf1 to AFF4 (Figure [6D](#F6){ref-type="fig"}), which is essential for the recruitment of P-TEFb to Paf1c for Ser2 phosphorylation (Figure [6](#F6){ref-type="fig"}). However, in the absence of DSIF, AFF1 depletion did not affect the binding of Paf1 to AFF4 (Figure [6D](#F6){ref-type="fig"}). These data indicate a sequential binding of AFF1 and AFF4 to Paf1c, i.e. the interaction of AFF1 with Paf1c is prior to the binding of AFF4 to Paf1c. Although the mechanism for such a sequential binding is currently unclear, this binding manner could be the underlying mechanism dictating the occurring sequence of pause release and Ser2 phosphorylation. Collectively, our data demonstrate that Ser2 phosphorylation occurs after pause release.

The mechanisms of P-TEFb recruitment by Brd4 and SEC {#SEC4-2}
----------------------------------------------------

How Brd4 mediates the recruitment of P-TEFb to promoter region is a question of interest to many researchers. While previous studies reported the interaction of P-TEFb with Med1, Med23, Tat-SF1 or DSIF ([@B22],[@B49]--[@B51]), our current data indicate that these factors are functionally connected to compose a Brd4/P-TEFb recruitment pathway which targets DSIF to regulate the pause release (Figure [8](#F8){ref-type="fig"}). However, how Brd4/P-TEFb complex transfers within this recruitment pathway and finally to DSIF is currently unclear. Since JQ1, an inhibitor interfering with the interaction of Brd4\'s bromodomains with its acetylated substrates ([@B48]), blocked the binding of Brd4/P-TEFb to Med1 (Figure [3D](#F3){ref-type="fig"}), it is likely that the binding of Brd4 to Med1 is through the association of Brd4\'s bromodomains with acetylated Med1. This might provide an insight into the inhibitory mechanism of JQ1 on Brd4\'s biological functions ([@B28]). It has to be noted that while this Brd4/P-TEFb recruitment process may represent a general mechanism, it is possible that other recruitment mechanisms might also exist ([@B37],[@B38],[@B52]), since depletion of Brd4 did not completely abolish HMBA-induced release of paused Pol II (Figure [1D](#F1){ref-type="fig"}).

The compositions of SEC vary with diverse subtypes depending on the cell types ([@B1],[@B33]). However, how each SEC subtype differentially regulates transcription elongation is still unknown. Our data reveal the functional differences of AFF1, AFF4 and ENL (AF9) in regulating pause release (Figure [8](#F8){ref-type="fig"}), but the role of ELLs in this process remains undetermined. Consistent with the observation that ENL (AF9) binds to Paf1c ([@B35]), we found that SEC subtypes containing ENL (AF9) recruited P-TEFbs via association with Paf1c, resulting in different functional consequences. For example, AFF1-ENL (AF9)-SEC recruited P-TEFb to phosphorylate NELF-A, whereas AFF4-ENL (AF9)-SEC recruited P-TEFb to phosphorylate Ser2 of Poll II (Figures [5](#F5){ref-type="fig"} and [6](#F6){ref-type="fig"}). Besides Paf1c, Med26 has also been reported to serve as a docking site for SEC/P-TEFb ([@B34]). We found that Med26 recruited AFF1- and AFF4-SEC/P-TEFb to NELF-E (Figure [5](#F5){ref-type="fig"}). Thus, together with Brd4/P-TEFb\'s recruitment pathway, Mediator- and Paf1c-coordinated P-TEFb recruitment creates a network that allows Brd4 and SEC to cooperatively regulate the release of transcriptionally paused Pol II.

In this study, we identified a mechanism by which Mediator and Paf1c coordinate with Brd4 and SEC subtypes to form a P-TEFb-recruitment network that dictates the transcriptional pause release. Whether and how this general mechanism applies to signal-specific or gene-specific release of pausing genes during stimulation will be the subject of future investigation. More importantly, the observation that AFF4 depletion abolishes Ser2 phosphorylation, but not the promoter--proximal pause release, provides an intriguing approach to define the specific functions of P-TEFb in other transcription-coupled events, such as splicing, 3′-end processing and termination.
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